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Abstract
Background: Osteopathic manipulative treatment (OMT) and ultrasound physical therapy (UPT)
are commonly used for chronic low back pain. Although there is evidence from a systematic review
and meta-analysis that OMT generally reduces low back pain, there are no large clinical trials that
specifically assess OMT efficacy in chronic low back pain. Similarly, there is a lack of evidence
involving UPT for chronic low back pain.
Methods: The OSTEOPAThic Health outcomes In Chronic low back pain (OSTEOPATHIC) Trial
is a Phase III randomized controlled trial that seeks to study 488 subjects between August 2006 and
June 2010. It uses a 2 × 2 factorial design to independently assess the efficacy of OMT and UPT for
chronic low back pain. The primary outcome is a visual analogue scale score for pain. Secondary
outcomes include back-specific functioning, generic health, work disability, and satisfaction with
back care.
Conclusion: This randomized controlled trial will potentially be the largest involving OMT. It will
provide long awaited data on the efficacy of OMT and UPT for chronic low back pain.
Trial registration: http://www.clinicaltrials.gov, NCT00315120
Background
Low back pain was the most common reason for office
visits to osteopathic physicians in the 1977–1978
National Ambulatory Medical Care Surveys [1]. More con-
temporary national surveys have shown that a majority of
patients who visit osteopathic physicians continue to
report receiving treatment for musculoskeletal disorders
[2], including osteopathic manipulative treatment (OMT)
[3]. Osteopathic physicians play a unique role in treating
patients with low back pain in the United States because
they may provide OMT in addition to or instead of con-
ventional medical treatment [4].
Osteopathic treatment of low back pain is based on four
key principles [5]: (1) the body is a unit; (2) the body pos-
sesses self-regulatory mechanisms; (3) structure and func-
tion are reciprocally interrelated; and (4) rational therapy
is based on an understanding of body unity, self-regula-
tory mechanisms, and the interrelationship of structure
and function. Several randomized clinical trials of OMT
for low back pain have been conducted [6-13]. These all
involved subjects in ambulatory settings; however, they
included relatively small numbers of subjects and were
characterized by variations in methodology and outcomes
among the trials. A meta-analysis of relevant data from
Published: 25 April 2008
Osteopathic Medicine and Primary Care 2008, 2:5 doi:10.1186/1750-4732-2-5
Received: 24 January 2008
Accepted: 25 April 2008
This article is available from: http://www.om-pc.com/content/2/1/5
© 2008 Licciardone et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Osteopathic Medicine and Primary Care 2008, 2:5 http://www.om-pc.com/content/2/1/5
Page 2 of 8
(page number not for citation purposes)
these trials found that subjects who received OMT experi-
enced significantly greater pain reduction than subjects
who received control treatments [14]. Nevertheless, com-
mentators continue to call for sufficiently powered trials
to assess the efficacy of OMT for low back pain [15].
Ultrasound physical therapy (UPT), often termed "thera-
peutic ultrasound," is a commonly used modality for
treatment of low back pain, with physical therapists
reporting use in 60% [16] to 80% [17] of cases. Ultra-
sound physical therapy consists of inaudible acoustic
vibrations delivered at a frequency between 0.75 and 3.0
MHz and intensity between 0.5 and 3 W/cm2 [18,19]. The
lower-frequency sound waves penetrate into deeper tis-
sues such as joints, muscles, and bones, and produce ther-
mal effects that are not normally perceived by patients.
There is evidence that ultrasound accelerates tissue regen-
eration, increases pain thresholds, stimulates bone
growth, and increases tendon extensibility [20]. As a deep-
heating modality, UPT may ameliorate subacute or
chronic soft-tissue inflammation via increased tissue tem-
perature or blood flow [21].
The Philadelphia Panel Evidence-Based Clinical Practice
Guidelines on Selected Rehabilitation Interventions for
Low Back Pain found only one small study that addressed
the efficacy of UPT for low back pain over 40 years ago
[22]. This randomized controlled trial involving 36 sub-
jects found no evidence of efficacy (i.e., pain reduction)
after one month of treatment when comparing continu-
ous ultrasound vs. placebo [23]. Consequently, the Phila-
delphia Panel concluded that there was poor evidence to
include or exclude UPT alone as an intervention for
chronic low back pain. More recently, the Working Group
on Guidelines for Chronic Low Back Pain concluded that
it could not recommend UPT as a treatment for chronic
low back pain [24].
Methods
Subject recruitment
Subjects will be recruited by advertising in local newspa-
pers and by seeking referrals from local physicians and
from clinics affiliated with the University of North Texas
Health Science Center. Subjects with constant or intermit-
tent low back pain for at least three months will be sought.
Terms other than "chronic low back pain" to be used in
recruiting subjects will include "backache," "sciatica," and
"lumbago." All subjects will be volunteers who are com-
pensated for their time and travel at each study visit. Con-
sent will be obtained from all subjects, and participants
may withdraw at any time without penalty. The flow of
subjects from recruitment through randomization is pre-
sented schematically in Figure 1.
Sample size and statistical power
The primary outcome will be change in low back pain
with OMT during the trial as measured by repeated visual
analogue scale (VAS) scores for pain over 12 weeks. Based
on recruitment and enrollment in the North Texas
Chronic Low Back Pain Trial [12], 488 subjects was a fea-
sible sample size target for the period August 2006
through June 2010. In a meta-analysis of the efficacy of
OMT for low back pain, an effect size of 0.26 was observed
for OMT vs. active treatment or placebo control [14].
Thus, using this assumed effect size, type I and type II error
rates of 0.05 and 0.20, respectively, 244 subjects assigned
to receive OMT (in either Group A or Group C) and 244
subjects assigned to receive sham OMT (in either Group B
or Group D), the estimated statistical power of the trial for
this pain outcome is 82%. For the secondary outcomes
based on widely used research instruments (i.e., the
Roland-Morris Disability Questionnaire [RMDQ] and the
Medical Outcomes Study Short Form – 36 [SF-36] Health
Survey), a total sample size of 488 will provide statistical
power greater than 95% in detecting clinically relevant
outcomes (a 2-point difference between groups on the
RMDQ [25] and a 10-point difference between groups on
the SF-36 general health scale [26]) with OMT.
Inclusion criteria
To be eligible for consideration as a trial subject, a partic-
ipant must meet all of the following telephone screening
criteria: (1) be between 21 and 69 years of age; (2) give a
positive response to the screening item, "Have you had
low back pain constantly or on most days for the last three
months?"; (3) identify low back as the primary site of
pain; (4) agree to forego any type of extra-trial manipula-
tion (either chiropractic or osteopathic) or physical ther-
apy; (5) understand and complete trial questionnaires in
English, or, if available, with appropriate translation serv-
ices for other languages; (6) give written informed consent
for clinical screening and, if selected, for trial participa-
tion; and (7) not be pregnant or plan to become pregnant
during the course of the trial. Participants of childbearing
potential will be required to have a negative urine preg-
nancy test and to be willing to maintain an acceptable
method of contraception throughout the trial to be eligi-
ble for consideration as a subject. Pregnant women will be
excluded from the study because back pain may resolve
spontaneously after pregnancy and because the effects of
UPT on the developing fetus are unknown.
Exclusion criteria
The following criteria will be used during telephone
screening to exclude potential subjects: (1) history of any
of the following conditions which may be underlying
causes of low back symptoms: (a) cancer; (b) spinal osteo-
myelitis; (c) spinal fracture; (d) herniated disc; (e) anky-
losing spondylitis; (f) cauda equina syndrome; (2) historyOsteopathic Medicine and Primary Care 2008, 2:5 http://www.om-pc.com/content/2/1/5
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of surgery involving the low back within the past year or
planned low back surgery in the future; (3) history of
receiving Worker's Compensation benefits within the past
three months; (4) involvement in current litigation relat-
ing to back problems; (5) current pregnancy or plan to
become pregnant during the course of the trial; (6) any of
the following that may limit a treatment provider's choice
of OMT techniques or hamper a subject's compliance with
the trial protocol: (a) angina or congestive heart failure
symptoms that occur at rest or with minimal activity; or
(b) history of a stroke or transient ischemic attack within
the past year; (7) any of the following that may represent
potential contraindications to receiving UPT: (a) implan-
tation of a cardiac pacemaker; (b) implantation of artifi-
cial joints or other biomedical devices; (c) active bleeding
or infection in the low back; or (d) pregnancy (8) use of
intravenous, intramuscular, or oral corticosteroids within
the past month; (9) history of chiropractic manipulation,
OMT, or UPT within the past three months or on more
than three occasions during the past year; or (10) being an
osteopathic physician, allopathic physician, chiropractor,
or physical therapist (or student of any of these profes-
sions).
Clinical screening
A written informed consent will be administered to those
participants who pass the initial telephone screening, and
they will then proceed to the clinical screening. The clini-
cal screenings will be performed by the same study per-
sonnel who provide the treatments. This clinical screening
serves to independently confirm trial eligibility based on
the telephone screening criteria described above, and pro-
vides an opportunity to clarify or update medical history
information, if needed, or to perform any other necessary
clinical examinations or tests to confirm continued trial
eligibility.
Because about 12% of ambulatory patients with back pain
have symptoms of sciatica or leg pain without neurologi-
cal compromise related to lumbar disc herniation [27],
such subjects will be included in this trial. However, to
minimize the likelihood of including participants with a
lumbar disc herniation, those with sciatica or leg pain will
not be allowed to continue in the trial if they test positive
for any of the following: (1) ankle dorsiflexion weakness;
(2) great toe extensor weakness; (3) impaired ankle
reflexes; (4) loss of light touch sensation in the medial,
dorsal, and lateral aspects of the foot; (5) ipsilateral
Flow of subjects from recruitment through randomization Figure 1
Flow of subjects from recruitment through randomization.
Trial Recruitment and Enrollment
August 2006 - June 2010
Telephone Screening
Clinical Screening
Randomization of Eligible Subjects to Treatment Group* (N=488)
ABCD
OMT + Sham OMT OMT + Sham OMT
UPT + UPT Sham UPT +Sham UPT
(n=122) (n=122) (n=122) (n=122)
*OMT denotes osteopathic manipulative treatment; UPT, ultrasound physical therapy. Osteopathic Medicine and Primary Care 2008, 2:5 http://www.om-pc.com/content/2/1/5
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straight leg raising test (positive result: leg pain at <60
degrees); or (6) crossed straight leg raising test (positive
result: reproduction of contralateral pain). These six neu-
rological tests will allow detection of most clinically sig-
nificant nerve root compromise due to L4-L5 or L5-S1 disc
herniations, which together make up over 90% of all clin-
ically significant radiculopathy attributable to lumbar disc
herniations [27].
Clinical trial protocol and timetable
Those subjects who pass the clinical screening process will
return for a two-hour session for: (1) a baseline osteo-
pathic history, examination, assessment, and treatment
plan; (2) randomization to a treatment group; and (3) the
initial (week 0) treatment session. Eligible subjects will be
randomized to one of the four treatment groups, using a
2 × 2 factorial design as shown in Figure 2. Subjects in
Group A will receive both active OMT and active UPT.
Subjects in Group B will receive sham OMT and active
UPT. Subjects in Group C will receive active OMT and
sham UPT. Subjects in Group D will receive sham OMT
and sham UPT. Blocked randomization will be performed
throughout the trial to ensure that comparable numbers
of subjects are assigned to each treatment group [28]. Sub-
jects will be randomized in blocks of 24 (4 treatment
groups × 6 subjects per treatment group) using computer
generated assignments. The clinical trial coordinators who
distribute and collect subject data forms at each study visit
will be blinded to treatment allocation.
Additional follow-up treatments and data collection will
occur during one-hour sessions, one, two, four, six, and
eight weeks post-randomization. Exit data collection will
be performed 12 weeks post-randomization. Treatment
providers will be specialists (including affiliated practic-
ing physicians), residents, or predoctoral fellows within
the Department of Osteopathic Manipulative Medicine of
the Texas College of Osteopathic Medicine at the Univer-
sity of North Texas Health Science Center. Subjects will be
allowed to receive usual care from their personal health
care providers. An overview of the clinical trial protocol
and timetable is presented in Table 1.
Active treatments
Osteopathic manipulative treatment
Osteopathic practice entails a physician-patient interac-
tion that is dynamic rather than static. Thus, OMT tech-
niques should be individualized to the patient, and may
need to be refined or changed over time based on the
patient's response to OMT. This is entirely consistent with
the view that different anatomical structures and physio-
logical mechanisms may underlie pain in different
patients with chronic low back pain. Ideally, practitioners
should address how structure and function may affect low
back pain and its progression, and then provide OMT by
combining the most appropriate techniques from among
the many available options [29].
Pragmatically, the trial protocol will be limited to the
OMT techniques that are listed in the Glossary of Osteo-
pathic Terminology [30]: articulatory treatment (ART),
balanced ligamentous tension/ligamentous articular
strain treatment (BLT), cranial treatment/osteopathy in
the cranial field/cranial osteopathy (CR), counterstrain
treatment (CS), direct treatment (DIR), facilitated posi-
tional release treatment (FPR), high velocity low ampli-
tude (thrust) treatment (HVLA), indirect treatment (IND);
integrated neuromusculoskeletal release (INR), ligamen-
tous articular strain/balanced ligamentous tension treat-
ment (LAS), muscle energy treatment (ME), myofascial
release treatment (MFR), soft tissue treatment (ST), and
visceral manipulative treatment (VIS). These 14 tech-
niques include the vast majority of techniques used in
patients with chronic low back pain.
In order to provide each subject with a comparable OMT
intervention across providers, subjects will be evaluated at
each encounter using the "dirty half dozen" framework
[31]. This approach accepts that six entities are often
encountered in patients with chronic low back pain: (1)
non-neutral lumbar somatic dysfunction; (2) dysfunction
of the symphysis pubis (pubic shear); (3) restriction of the
anterior movement of the sacral base; (4) innominate
shear dysfunction; (5) a short leg and pelvic tilt syndrome;
2 × 2 Factorial design Figure 2
2 × 2 Factorial design.
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and (6) muscular imbalance of the trunk and lower
extremity (including psoas syndrome).
Subjects initially will be evaluated in the seated position
for thoracic and lumbar somatic dysfunction. Screening in
this position allows for not only tri-planar dysfunction
diagnosis, but also for determination of areas of greater
restriction, which may help the treatment provider deter-
mine where to initiate treatment within a given session.
Key findings, including lumbar segmental dysfunction,
non-neutral lumbar dysfunction, and lumbar muscle
hypertonicity also will be graded as "0" for no dysfunc-
tion, "1" for mild to moderate dysfunction, and "2" for
severe dysfunction. Subjects will be evaluated in the prone
position for sacral landmarks and motion testing. This
evaluation will assess sacral dysfunctions, including for-
ward and backward sacral torsions, unilateral and bilat-
eral flexion and extension lesions, and sacral shears. Sacral
dysfunction will be graded on the same 0–2 scale
described above for lumbar dysfunction. Subjects will be
placed in left and right lateral recumbent positions for
lumbar soft tissue, muscle energy, and high velocity low
amplitude techniques. While in this position, sacral tor-
sion muscle energy may be applied. Subjects will be
placed in the supine position for pelvic landmark evalua-
tion and motion testing. Particular attention will be paid
to pubic dysfunction, iliac rotation, and iliac shears.
Screening and treatment, if indicated, will be provided for
psoas and anterior lumbar counterstrain points. Innomi-
nate dysfunction will be graded on the previously
described 0–2 scale. Treatment providers will perform up
to five additional OMT techniques based upon their eval-
uation of the subject and the subject's response to the
standard protocol.
Ultrasound physical therapy
The UPT will include ultrasound as used in physical med-
icine and rehabilitation programs for a variety of muscu-
loskeletal disorders [21,32]. The anatomical areas of the
low back to be treated will be based on physical findings
from the baseline osteopathic examination, assessment,
and treatment plan. The UPT will be administered by the
same providers who administer OMT. To achieve heating
of deeper tissues, the UPT unit will be set to an intensity
level of 1.2 W/cm2, using a frequency of 1 MHz. A 10 cm2
applicator will be applied directly to the skin using a con-
ductivity gel to enhance ultrasound absorption. The UPT
intervention will last approximately 10 minutes, allowing
the provider to treat about 150 to 200 cm2 in the target
treatment area and thereby produce deep muscle temper-
ature elevations approaching 4°C. This heating effect may
ameliorate symptoms of chronic pain and inflammation.
As there are no previous studies that have evaluated the
combination of OMT and UPT, we will provide OMT
prior to UPT to avoid potential difficulties in performing
OMT after the administration of ultrasonic conductivity
gel to the target treatment area. Subjects will be instructed
to report any uncomfortable thermal (e.g., excessive heat
or burning) or mechanical (e.g., excessive friction or
trauma) effects at the treatment sites. Such reports will
trigger treatment providers to reduce the intensity of the
UPT to alleviate the reported discomfort or, if necessary,
to discontinue the UPT for that session.
Table 1: Clinical trial protocol and timetable
Task* Pre-Randomization Weeks Post-Randomization
0124681 2
Recruitment ●
Telephone screening ●
Clinical screening ●
Data collection
Sociodemographic data ●
Visual analogue scale for low back pain ● ●●●●●● ●
Roland-Morris Disability Questionnaire ●● ● ●
Medical Outcomes Study Short Form – 36 Survey ●● ● ●
Work disability measure ●● ● ●
Patient satisfaction measure ●● ●
OOSNF-History ●
OOSNF-Examination ●
OOSNF-Assessment and Plan ●●●●●●
Randomization ●
Allocated treatment ●●●●●●
*OOSNF denotes Outpatient Osteopathic SOAP Note Form.Osteopathic Medicine and Primary Care 2008, 2:5 http://www.om-pc.com/content/2/1/5
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Placebo control treatments
Sham OMT was adapted from the methodology estab-
lished in the North Texas Chronic Low Back Pain Trial
[12]. The treatment will include hand contact with mini-
mal movement of body parts. The intent of the sham
OMT is to apply manual forces of diminished magnitude
purposely aimed to avoid treatable areas of somatic dys-
function relative to low back pain and, consequently, to
minimize the likelihood of any therapeutic effect. Because
sham OMT in the preliminary trial provided some thera-
peutic effect [12], the baseline osteopathic examination,
assessment, and treatment plan will be used to guide the
selection of anatomical regions for sham OMT, with the
intent of avoiding those areas of somatic dysfunction that
contribute most to the subject's low back pain.
Subjects assigned to receive sham OMT will be treated in
positions similar to subjects receiving active OMT. Sham
OMT subjects will receive several minutes of hands-on
time in the seated position with attention paid to the tho-
racic and lumbar spine regions. Sham OMT subjects will
also receive hands-on time in the prone and supine posi-
tions, including hands-on contact of the sacrum in the
prone position and pelvic landmark examination in the
supine position.
Sham UPT will be based on the methodology used in a
previous trial of OMT in third-trimester pregnancy [33].
This treatment will provide tactile and manual stimula-
tion of the low back and other anatomical areas that will
be treated with active or sham OMT. These anatomical
areas will be based on findings from the baseline osteo-
pathic examination, assessment, and treatment plan to
maximize placebo credibility and expectations. Subthera-
peutic ultrasound will be provided by setting the ultra-
sound unit to 0.1 W/cm2 intensity at 1 MHz; however, the
applicator head will be applied directly to the subject's
skin in the low back using ultrasonic conductivity gel to
simulate in all other respects the actual UPT maneuvers
described above.
Baseline data collection
Baseline data will be collected at the clinical screening
visit prior to randomization. This includes sociodemo-
graphic data, insurance status, and a VAS for low back
pain, which serves as the primary outcome measure.
Other baseline measures include back-specific function-
ing (RMDQ), generic health status (SF-36), work disabil-
ity, and back-specific satisfaction, as these are secondary
outcome measures that address the four remaining recom-
mended domains of patient-based outcomes in evaluat-
ing the treatment of spinal disorders [34]. Repeated
measures of the primary and secondary outcome variables
will be performed during the trial as indicated in Table 1.
Additional data relevant to low back pain, medical comor-
bidities, and other co-treatments will also be collected.
Visual analogue scale
The VAS will consist of a 100-mm horizontal line labeled
as "no pain" at its left end (measured as 0 mm) and as
"worst possible pain" at its right end (measured as 100
mm). This measure is commonly used to assess changes in
pain over time and has been recommended as an outcome
measure in studies of spinal disorders such as low back
pain [35]. It has been shown that data derived from such
written scales among patients with chronic low back pain
are normally distributed even when the scales are used
without verbal instructions [35].
Roland-Morris Disability Questionnaire
Functional status and disability resulting from back pain
will be measured with the RMDQ [36]. This question-
naire, which was derived from the Sickness Impact Profile,
is short and simple to complete and appears to be well
suited for studies involving patients with mild to moder-
ate disability [37]. Empirical research suggests that the
RMDQ poses less problems involving blank or multiple
responses than either the Oswestry Disability Index or the
Jan van Breemen Institute pain and functional capacity
questionnaire and, therefore, may be the preferred instru-
ment for assessing change over time in patients with low
back pain [38]. The RMDQ consists of a series of 24 items.
It is scored as the number of positive responses to these
items, with higher scores reflecting greater functional dis-
ability.
Medical Outcomes Study Short Form – 36 Health Survey
The SF-36 will be used to measure generic health status. It
is widely used for this purpose and has been used exten-
sively in measuring clinical outcomes following medical
interventions. The SF-36 provides data on health concepts
using the following scales [26]: physical functioning, role
limitations because of physical problems, bodily pain,
general health, vitality, social functioning, role limitations
because of emotional problems, and mental health. Con-
struct validity of the SF-36 was established by factor anal-
ysis [39]. Studies including the internal consistency
method, Cronbach's coefficient alpha, and test-retest coef-
ficients support use of the SF-36 in detecting short-term
changes in health, such as those being measured in this
trial [26]. The reliability of the SF-36 has also been dem-
onstrated by test-retest correlations based on intervals as
long as six months between administrations [26].
Responses to each of the 36 survey items will be recorded
and then standardized scores (ranging from 0 for worst
possible health to 100 for best possible health) will be
computed for each of the eight scales described above
using the recommended algorithms. The SF-36 generalOsteopathic Medicine and Primary Care 2008, 2:5 http://www.om-pc.com/content/2/1/5
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health scale score will be the main focus of interest, as this
represents a secondary outcome in the trial.
Work disability
Subjects who work will be asked to complete the follow-
ing survey item: "During the past four weeks, how many
days did back pain keep you from going to work?" A
response section will allow for two digits and instructions
will specify to record "00" if no work loss occurred.
Satisfaction with back care
Satisfaction with back care will be measured by responses
to the following item: "Overall, how would you describe
your satisfaction with the care for your back that you have
received?" Likert-scale response options will include:
"very satisfied," "satisfied," neither satisfied nor dissatis-
fied," "dissatisfied," or "very dissatisfied."
Data management and analysis
The data will be entered into the SPSS for Windows soft-
ware package (SPSS Inc, Chicago, IL) by independent
research personnel using standardized formats and dual
data entry to minimize keying errors. Statistical analyses
will be performed using the intention-to-treat principle.
Analysis of variance (ANOVA) will be the primary method
of statistical analysis. This has the advantages of allowing
for assessment of repeated outcome measures over time,
interaction of the factors being studied, and control of
important confounders if indicated. Missing values for
outcome measures will be imputed using the last observa-
tion carried forward method.
Ethical aspects
The study protocol was approved by the Institutional
Review Board (IRB) of the University of North Texas
Health Science Center prior to implementation. The IRB
will continue to monitor the study regularly. Additionally,
a Data Safety and Monitoring Board (DSMB) has been
established, and will closely monitor the study for the
occurrence of any serious adverse events. The study was
registered as a Phase III trial with ClinicalTrials.gov in
April 2006 (ClinicalTrials.gov identifier, NCT00315120).
Conclusion
To the best of our knowledge, if successfully completed as
described herein, the OSTEOPATHIC Trial will be the
largest randomized controlled trial involving OMT. It will
provide long awaited primary data on the efficacy of OMT
and UPT for chronic low back pain.
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